Involved field (IF) radiotherapy is as effective as extended field (EF) radiotherapy after 2 cycles of COPP/ABVD in patients (pts) with intermediate-stage Hodgkin's disease (HD): A randomized multicenter study.

被引：0
|
作者：
Engert, A [1 ]
Schiller, P [1 ]
Pfistner, B [1 ]
Herrmann, R [1 ]
Koch, P [1 ]
Bossevin, F [1 ]
Schaber, R [1 ]
Loeffler, M [1 ]
Duehmke, F [1 ]
Mueller-Hermelink, HK [1 ]
Paulus, U [1 ]
Rueffer, JU [1 ]
Sieber, M [1 ]
Wolf, J [1 ]
Diehl, V [1 ]
机构：
[1] Univ Cologne, German Hodgkins Study Grp, Med Ctr, Cologne, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3199
引用
收藏
页码：768A / 768A
页数：1
相关论文
共 50 条
  • [21] Second interim analysis of the HD7 trial of the GHSG:: 2 cycles ABVD plus extended field radio-therapy is more effective than radiotherapy alone in early stage HD.
    Tesch, H
    Sieber, M
    Rüffer, JU
    Franklin, J
    Herrmann, R
    Boissevain, F
    Franke, A
    Pfreundschuh, R
    Hossfeld, D
    Dühmke, E
    Wolf, J
    Engert, A
    Paulus, U
    Diehl, V
    BLOOD, 1999, 94 (10) : 268B - 268B
  • [22] PATTERNS OF RELAPSE IN LOCALIZED (STAGE-1 AND STAGE-2) HODGKINS-DISEASE (HD) FOLLOWING EXTENDED FIELD RADIOTHERAPY (EFXRT) VS INVOLVED FIELD RADIOTHERAPY (IFXRT) PLUS MOPP
    COLTMAN, CA
    FULLER, LM
    BLOOD, 1977, 50 (05) : 188 - 188
  • [23] Involved field(IF) vs. extended field (EF) radiotherapy (RT) for patients in early unfavorable stages of Hodgkin's lymphoma (HL): 10-year update of the HD8 trial of the German Hodgkin Study Group (GHSG)
    Kriz, J.
    Sasse, S.
    Klimm, B.
    Goergen, H.
    Mueller, R. -P
    Diehl, V
    Borchmann, P.
    Engert, A.
    Eich, H. -T
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 30 - 30
  • [24] ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Long-term results
    Bonadonna, G
    Bonfante, V
    Viviani, S
    Di Russo, A
    Villani, F
    Valagussa, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 2835 - 2841
  • [25] Elderly patients with early-unfavorable stage Hodgkin's disease (HD) have a poorer outcome when treated with combined modality treatment and extended field radiotherapy (EF): A retrospective analysis of the German Hodgkin study group.
    Engert, A
    Haverkamp, H
    Eich, HT
    Josting, A
    Pfistner, B
    Diehl, V
    BLOOD, 2004, 104 (11) : 368A - 368A
  • [26] Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's lymphoma: Interim analysis of the German Hodgkin study group trial HDIO
    Eich, H
    Mueller, R
    Engert, A
    Hansemann, K
    Skripnitchenko, R
    Pfistner, B
    Lukas, P
    Willich, N
    Diehl, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S1 - S2
  • [27] Four cycles of ABVD followed by involved field irradiation (IF-RT) is the treatment of choice for early-stage Hodgkin's disease (HD): 5-year results of a randomized trial
    Santoro, A
    Bonfante, V
    Viviani, S
    Zanini, M
    Devizzi, L
    Parra, HS
    DiRusso, A
    Soncini, F
    Villani, F
    Valagussa, P
    Bonadonna, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1185 - 1185
  • [28] Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and Involved Field Radiotherapy (IF-RT) Is Superior to 4 Cycles of ABVD and IF-RT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial
    Borchmann, Peter
    Engert, Andreas
    Pluetschow, Annette
    Fuchs, Michael
    Markova, Jana
    Lohri, Andreas
    Kral, Zdenek
    Greil, Richard
    Topp, Max
    Villalobos, Matthias
    Zijlstra, Jose
    Soekler, Martin
    Stein, Harald
    Eich, Hans Theodor
    Mueller, Rolf Peter
    Diehl, Volker
    BLOOD, 2008, 112 (11) : 143 - 143
  • [29] Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and Involved Field Radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin Lymphoma (HL): An analysis of the GHSG HD14 trial
    Eich, H. T.
    Borchmann, P.
    Kriz, J.
    Pluetschow, A.
    Fuchs, M.
    Engert, A.
    Mueller, R. -P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 77 - 77
  • [30] Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs 40 Gy extended field radiotherapy alone
    Duhmke, E
    Diehl, V
    Loeffler, M
    Mueller, RP
    Ruehl, U
    Willich, N
    Georgii, A
    Roth, S
    Matthaei, D
    Sehlen, S
    Brosteanu, O
    Hasenclever, D
    Wilkowski, R
    Becker, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (02): : 305 - 310
12345